The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Culturally Aware AET Non-Initiation Intervention
Official Title: Addressing Non-Initiation of Recommended Adjuvant Endocrine Therapy With a Culturally Informed-Intervention
Study ID: NCT05465408
Brief Summary: The purpose of this study is to examine the feasibility and acceptability of a brief, nurse-led intervention to support breast cancer survivors who have delayed initiation of hormonal therapy or who have concerns about starting hormonal therapy.
Detailed Description: This is a single-arm pilot trial to examine the feasibility and acceptability of a patient-centered, evidence-based, culturally competent, nurse-led intervention to encourage breast cancer survivors who have not begun taking adjuvant endocrine therapy (AET) to initiate the medication. The research study procedures include: * screening for eligibility * two individual study intervention sessions * study assessment follow-up questionnaires This research study involves two individual sessions with a nurse practitioner which will take place via videoconferencing sessions either in-person or via telephone. Participants will also complete three brief questionnaire packets over the 12-week course of the study. It is expected that up to 35 people will take part in this research study. The investigators plan to enrich the study sample for patients of a racial and/or ethnic minority in order to ensure the generalizability of the study findings.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Dana-Farber Cancer Institute at St Elizabeth's Medical Center, Brighton, Massachusetts, United States
Emerson Hospital/MGH Cancer Center, Concord, Massachusetts, United States
Mass General at North Shore Cancer Center, Danvers, Massachusetts, United States
Dana-Farber Brigham Cancer Center - Foxborough, Foxboro, Massachusetts, United States
Dana-Farber Cancer Institute - Merrimack Valley, Methuen, Massachusetts, United States
Dana-Farber Brigham Cancer Center at Milford Regional Medical Center, Milford, Massachusetts, United States
Mass General at Newton Wellesley Hospital, Newton, Massachusetts, United States
Dana-Farber Brigham Cancer Center with South Shore Hospital, Weymouth, Massachusetts, United States
Dana-Farber/New Hampshire Onoclogy-Hematology, Londonderry, New Hampshire, United States
Name: Jamie M Jacobs, PhD
Affiliation: Massachusetts General Hospital
Role: PRINCIPAL_INVESTIGATOR